Source: PR Newswire

Press Release: Terumo : Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR 3.0 Software for Coronary Physiology Assessment in the US

/PRNewswire/ -- Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), today announced that Medis QFR 3.0, an FDA-cleared software...

Read full article »
Terumo's Competitors | Terumo's News | Terumo's Financials
Stay up-to-date with the latest news on Terumo
Annual Revenue
$5.0-10B
Employees
10-50K
Shinjiro Sato's photo - President & CEO of Terumo

President & CEO

Shinjiro Sato

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on Terumo